Onconetix, Inc. Payments for Repurchase of Initial Public Offering
Onconetix, Inc. (ONCO) reported Payments for Repurchase of Initial Public Offering of $3.5 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2024-04-11
- Onconetix, Inc. payments for repurchase of initial public offering for the quarter ending 2023-09-30 was -$3.50M.
- Onconetix, Inc. payments for repurchase of initial public offering for the quarter ending 2022-03-31 was $104.03K.
- Onconetix, Inc. payments for repurchase of initial public offering for fiscal 2022 was $926.97K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $3.50 10-Q · filed 2023-11-17 | ||
| 2023-06-30 | $3.50M 10-Q · filed 2023-10-20 | |||
| 2022-12-31 | $926.97K 10-K · filed 2024-04-11 | |||
| 2022-03-31 | $104.03K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |